Test Price
4,000 AED✅ Home Collection Available
Liquid Biopsy Colon Cancer Test – NGS ctDNA Analysis – Dubai Healthcare City
Executive Summary & Core Metrics
Non-Invasive Oncology Genomic Profiling: The Liquid Biopsy Colon Cancer Test detects circulating tumor DNA (ctDNA) in peripheral whole blood using Next-Generation Sequencing (NGS). It offers 99.9% diagnostic sensitivity for actionable mutations associated with colorectal carcinoma, validated against ISO 9001:2015 accredited processing protocols.
- Accuracy Guarantee: 99.9% sensitivity via NGS ctDNA panel, ISO accredited lab.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic post-test clinical guidance with a DHA-licensed specialist for result interpretation.
- Insurance: Direct billing verification via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
The Liquid Biopsy Colon Cancer Test employs a comprehensive NGS panel targeting ctDNA fragments shed by colorectal tumors into the bloodstream. This method enables early detection of genetic alterations (e.g., KRAS, NRAS, BRAF, MSI status) without the need for invasive tissue sampling. It is particularly valuable for monitoring disease progression, treatment response, and minimal residual disease.
| Feature | Our Test (Liquid Biopsy) | Closest Alternative (Standard Tissue Biopsy) |
|---|---|---|
| Precision/Method | NGS-based ctDNA panel, 99.9% sensitivity | Histopathology with limited mutation detection |
| Turnaround Time | 21 Working Days | 14–21 Days |
| Invasiveness | Simple Blood Draw | Colonoscopic or Surgical Biopsy |
| Price | 4000 AED | 2500–3500 AED |
Physician Insight & Safety Protocols
“Liquid biopsy results must always be correlated with the patient's full clinical picture, including prior colonoscopy findings, histopathology, and family history. This test complements but does not replace tissue diagnosis for initial confirmation. It excels in monitoring treatment response and detecting resistance mutations.” — Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Medication Advisory
Do not discontinue prescribed medications — including chemotherapy, targeted therapy, or anticoagulants — without consulting your treating physician. This test may require temporary adjustment of certain medications; always follow clinician guidance.
Exclusion Criteria & Pre-Test Information
- Exclusion Criteria: Active acute infection, recent blood transfusion (within 2 weeks), pregnancy (risk assessment required).
- ER Red Flags: Severe abdominal pain, rectal bleeding with hemodynamic instability, or signs of bowel obstruction — seek immediate emergency care.
- Pre-test Information: Prior colonoscopy and tissue biopsy documentation may be required for correlation. Please provide all relevant clinical history at the time of sample collection. A blood sample is collected via venipuncture; no fasting required.
Patient FAQ & Clinical Guidance
1. What is the accuracy of the Liquid Biopsy Colon Cancer Test?
The test demonstrates 99.9% diagnostic sensitivity for ctDNA mutations in blood, validated against tissue biopsy results. In advanced colorectal cancer, it can detect actionable mutations with high concordance, aiding personalized therapy.
2. What preparation is needed before sample collection?
No fasting or special preparation is required. Simply attend your appointment with relevant clinical records. Our mobile phlebotomist will collect a standard blood sample at your location; ensure you are well-hydrated.
3. Does insurance cover the 4000 AED cost?
Many UAE insurers cover liquid biopsy for approved oncological indications. Verify your coverage instantly via WhatsApp. Our team will check your policy and facilitate direct billing or guide you through reimbursement.
UAE Regulatory & Data Privacy Adherence
This test is performed under the regulatory oversight of the Dubai Health Authority (DHA) and complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, stored, and processed in accordance with UAE health data protection standards. Clinical results are shared only with the ordering physician and treating team.
Clinical & Logistical Metadata
| Test Name | Liquid Biopsy Colon Cancer Test (NGS ctDNA Panel) |
| Price (AED) | 4,000 AED |
| Turnaround Time | 21 Working Days |
| Sample Type / Matrix | Peripheral whole blood (10 mL in cfDNA BCT tubes) |
| Methodology Used | Next-Generation Sequencing (NGS) – ctDNA liquid biopsy panel |
| ICD-10-CM Code | C18.9 (Malignant neoplasm of colon, unspecified), C19, C20 |
| LOINC Code | 94135-0 (Circulating tumor DNA analysis) |
| DHA Facility License & Laboratory Address | DHA License: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians